Skip to main content
Year archive

ALTERITY THERAPEUTICS LIMITED — 2019 filings

All 31 regulatory filings released by ALTERITY THERAPEUTICS LIMITED (ATH) in 2019, sourced directly from the official regulator.

31 Filings
2019 Period
2019 filings (31)
Filing Released Lang
Upcoming Release of warrants from Voluntary Escrow 1
Regulatory Filings
2019-12-10 English
Chairman's Address to Shareholders 2 pages 160.5KB
AGM Information
2019-11-25 English
AGM Presentation 2019 12 pages 795.4KB
AGM Information
2019-11-25 English
AGM Results of Meeting 2 pages 180.2KB
Declaration of Voting Results & Voting Rights Announcements
2019-11-25 English
Appendix 3B 12 pages 354.3KB
Capital/Financing Update
2019-11-20 English
Alterity AGM Investor Conference Call 2 pages 266.4KB
AGM Information
2019-11-19 English
Lead drug candidate receives positive opinion from EMA 2 pages 159.5KB
Regulatory Filings
2019-11-17 English
Appendix 4C - quarterly 7 pages 356.0KB
Interim / Quarterly Report
2019-10-29 English
Notice of Annual General Meeting/Proxy Form 20 pages 1.2MB
AGM Information
2019-10-24 English
ATH presents PBT434 clinical data at the 2019 MDS Congress 2 pages 218.7KB
Regulatory Filings
2019-09-23 English
Alterity to Present at the Janney Healthcare Conference 2 pages 232.0KB
Investor Presentation
2019-09-08 English
Form 20-F 124 pages 857.0KB
Annual Report
2019-09-01 English
Annual Report 2019 and XBRL data filed with the SEC 1
Report Publication Announcement
2019-09-01 English
Appendix 4E & Annual Report 2019 96 pages 1.5MB
Annual Report
2019-08-29 English
Appendix 4G & Corporate governance statement 2019 22 pages 353.2KB
Governance Information
2019-08-29 English
Change in substantial holding 3 pages 1.0MB
Regulatory Filings
2019-08-19 English
Upcoming Release of Shares from Voluntary Escrow 2 pages 300.0KB
Major Shareholding Notification
2019-08-04 English
Appendix 3B 11 pages 358.5KB
Capital/Financing Update
2019-07-31 English
Appendix 4C - quarterly 7 pages 383.9KB
Interim / Quarterly Report
2019-07-30 English
Successful Completion of Phase 1 Clinical Trial 2 pages 204.4KB
Regulatory Filings
2019-07-28 English
Alterity Therapeutics presents to Finance News Network 19 pages 1.3MB
Investor Presentation
2019-06-03 English
Ceasing to be a substantial holder - ATH 2 pages 409.7KB
Major Shareholding Notification
2019-06-03 English
Prospectus filed pursuant to SEC Rule 424(b)(3) 20 pages 443.4KB
Capital/Financing Update
2019-05-22 English
Upcoming Release of Shares from Escrow 2 pages 206.9KB
Regulatory Filings
2019-05-19 English
FORM F-3 33 pages 877.8KB
Capital/Financing Update
2019-05-13 English
Alterity Therapeutics commences US investor meetings 2 pages 209.8KB
Investor Presentation
2019-05-12 English
Becoming a substantial holder 67 pages 2.3MB
Regulatory Filings
2019-05-07 English
Form 603 Notice lodged by Bank of New York Mellon 2 pages 210.4KB
Major Shareholding Notification
2019-05-07 English
Alterity presents initial Phase 1 clinical trial data at AAN 15 pages 742.0KB
Investor Presentation
2019-05-05 English
ATH presents at the American Academy of Neurology 3 pages 244.2KB
Investor Presentation
2019-05-02 English
Appendix 4C - quarterly 5 pages 171.2KB
Interim / Quarterly Report
2019-04-16 English